Thorsten Füreder

<scp>PD</scp>‐1 and <scp>PD</scp>‐L1 expression in <scp>HNSCC</scp> primary cancer and related lymph node metastasis – impact on clinical outcome

Sven Schneider, Lorenz Kadletz, Robert Wiebringhaus et al. · Histopathology · 2018 · 105 citations

Medicine, Oncology, Pathology +17

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

Elisabeth L. Zeilinger, Claudia Oppenauer, Matthias Knefel et al. · Epidemiology and Psychiatric Sciences · 2022 · 69 citations · Full text

Medicine, Oncology, Psychiatry +15

The PI3-Kinase/mTOR-Targeting Drug NVP-BEZ235 Inhibits Growth and IgE-Dependent Activation of Human Mast Cells and Basophils

Katharina Blatt, Harald Herrmann, Irina Mirkina et al. · PLoS ONE · 2012 · 26 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial

Felix Keil, Maximilian Hartl, Gabriela Altorjai et al. · European Journal of Cancer · 2021 · 20 citations

Medicine, Oncology, Chemotherapy +7

Safety and feasibility of every‐other‐week maintenance cetuximab after first‐line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer

Paolo Bossi, Gabriela Kornek, Gaetano Lanzetta et al. · Head & Neck · 2012 · 19 citations

Pharmacy, Oncology, Pharmacotherapy +14